Clinical Trial Update: Assesment of a Predictive Model Dosage of EPO in Hemodialysis Patients

View source ↗

Summary

This clinical trial update evaluates a predictive model for dosing epoetin alfa in anemia among hemodialysis patients. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: NephroCare Spain | Conditions: Anemia | Status: UNKNOWN